The Word Lab
Keeping industry professionals up-to-date with the latest news affecting life science translations
All Posts
Topic

Regulatory


Early Potential in Human Trials for COVID-19 Vaccine

Early Potential in Human Trials for COVID-19 Vaccine

BioNTech, a German based biotech company, and Pfizer, the well-established pharmaceutical company headquartered in the United States, have partnered to produce one of the 17 COVID-19 vaccines currently in development. The vaccine has shown promising early-stage human...
Gilead Sets Price for Remdesivir

Gilead Sets Price for Remdesivir

Gilead Sciences, the biotech company based out of California that created one of the first original treatments for COVID-19, has set the price for remdesivir between $2,340 and $3,120 for a typical course treatment. While remdesivir has still yet to prove to reduce...